New Delhi, 2nd December 2021: COVID-19 variants have profoundly changed the trajectory of the pandemic across the world. It is important to get tested to reduce risk due to concerns like the coronavirus's infectious nature, immune system evasion and vaccine resistance. The new strain Omicron
Simultaneously detects HCV core antigen and anti-HCV antibodies for more accurate screening Reduces window period to less than 28 days, resulting in earlier diagnosis Next-gen testing solution suitable for blood banks Transasia Bio-Medicals Ltd., India’s Leading In-vitro Diagnostic Company, committed to a Healthier India,
